Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research Units
Projects
Activities
Datasets
Equipment
Prizes
Press / Media
Search by expertise, name or affiliation
ANICCA-Class II : A phase II Trial of nivolumab in strong class II expressing microsatellite stable colorectal cancer patients (MSS CRC)
Billingham, Lucinda
(Co-Investigator)
Middleton, Gary
(Principal Investigator)
Cancer Clinical Trials Unit
Immunology and Immunotherapy
Overview
Project Details
Short title
ANICCA-Class II : A phase II Trial of nivolumab in strong class II expressing microsatellite stable colorectal cancer patients (MSS CRC)
Status
Active
Effective start/end date
1/01/18
→
31/12/23
Funding
BRISTOL MYERS SQUIBB PHARMACEUTICALS
View all
View less